Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Trial of the Adrenergic Alpha-1 Antagonist Prazosin for Alcohol Dependence

NCT00762710 is registered in ClinicalTrials.gov with Seattle Institute for Biomedical and Clinical Research as lead sponsor.

NCT NCT00762710
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00762710 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Trial of the Adrenergic Alpha-1 Antagonist Prazosin for Alcohol Dependence
Lead sponsor
Seattle Institute for Biomedical and Clinical Research
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2008
Completion date
June 30, 2014
Enrollment
92 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcoholism